Antibiotic Prophylaxis in Urology Departments, 2005–2010

Çek, Mete; Tandoğdu, Zafer; Naber, Kurt G.; Tenke, Péter; Wagenlehner, Florian M. E.; Oostrum, Edgar van; Kristensen, Brian; Johansen, Truls E. Bjerklund

doi:10.1016/j.eururo.2012.09.038

Cited by 67 publications

(45 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Routine antibiotic prophylaxis of all urological procedures was highest in Asia, Africa and Latin America with 86%, 85% and 84%, followed by Europe with 67%. Antibiotic prophylaxis was not always consistent with recommended guidelines [22]. Tandogdu et al, showed that resistance to almost all pathogens isolated during UTI was lowest in North Europe, with no single year where an outbreak of resistance has been detected [23].…”

Section: Discussionmentioning

confidence: 99%

The analysis of antibiotic consumption and bacterial resistance in tertiary Healthcare Centre Nis

Velickovic-Radovanovic¹,

Stefanović²,

Damnjanovic³

et al. 2016

Hosp Pharm Int Multi J

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

The analysis of antibiotic consumption and bacterial resistance in tertiary Healthcare Centre Nis

Velickovic-Radovanovic¹,

Stefanović²,

Damnjanovic³

et al. 2016

Hosp Pharm Int Multi J

View full text Add to dashboard Cite

“…The European Association of Urology (EAU) guidelines on urologic infections summarise evidence supporting the routine use of antibiotic prophylaxis for specific urologic procedures, and use the evidence to set out recommendations on whether or not to use preoperative prophylaxis for urologic procedures categorized according to risk categories for postoperative infection [2]. Adherence to the EAU guidelines is not universal, with considerable unwarranted variation among countries, regions, and types of hospital for preoperative prophylaxis and the agents used [3]. An additional problem is extended duration of antibiotic administration after a surgical procedure without any infective indication.…”

Section: Introductionmentioning

confidence: 99%

“…However, prophylaxis use should be riskadjusted according to the procedure to ensure that harms in terms of bacterial resistance in an individual and society do not outweigh the benefits [2,3]. The European Association of Urology (EAU) guidelines on urologic infections summarise evidence supporting the routine use of antibiotic prophylaxis for specific urologic procedures, and use the evidence to set out recommendations on whether or not to use preoperative prophylaxis for urologic procedures categorized according to risk categories for postoperative infection [2].…”

Section: Introductionmentioning

confidence: 99%

Adherence to European Association of Urology Guidelines on Prophylactic Antibiotics: An Important Step in Antimicrobial Stewardship

et al. 2016

View full text Add to dashboard Cite

“…Resistant uropathogens causing HAUTIs and consequent high antibiotic usage is a major concern [4]. As a consequence, classical smaller-spectrum antibiotics, such as co-trimoxazole and 2nd-generation cephalosporins, and in some areas even fluoroquinolones, can no longer be recommended for PAP because of increasing frequency of resistant uropathogens.…”

Section: Aimmentioning

confidence: 99%

Fosfomycin Trometamol (3,000 mg) in Perioperative Antibiotic Prophylaxis of Healthcare-Associated Infections after Endourological Interventions: A Narrative Review

2013

View full text Add to dashboard Cite

Introduction: Increasing antibiotic resistance also has an impact on perioperative antibiotic prophylaxis (PAP). This narrative review evaluates fosfomycin trometamol (FT) as PAP in endourological interventions. Materials and Methods: Nine clinical studies including 4 randomized comparative studies were analyzed. A total of 1,614 patients received FT as PAP for different endourological procedures and extracorporeal shock wave lithotripsy [ESWL; i.e. cystoscopy (n = 498), urodynamic studies (n = 39), ureteropyeloscopy (n = 10), urethrotomy (n = 20), lithotripsy (n = 15), transurethral resection of bladder tumors (n = 139), transurethral resection of the prostate (n = 843), ESWL (n = 20), ureterorenoendoscopic lithotripsy (n = 18), percutaneous nephrostomic lithotripsy (n = 12)]. Results: In 8 clinical studies, FT was shown to be effective in preventing healthcare-associated urinary tract infections (HAUTIs). One study showed no benefit. The usual dosage regimen was oral administration of 3 g of FT 3 h before and 24 h after the procedure. In 1 randomized comparative study investigating HAUTIs after diagnostic cystoscopy, it could also be shown that a single oral dose of 3 g of FT 3 h before cystoscopy was as effective as a double dose. Conclusion: According to the published results, for traumatic endourological interventions and surgical procedures, an oral dosage of 3 g of FT 3 h before and 24 h after the procedure and only 1 (prior) oral dosage for diagnostic procedures might be an alternative if PAP is indicated. Limitations of the studies are the low numbers of patients included for most indications.

show abstract

Antibiotic Prophylaxis in Urology Departments, 2005–2010

Cited by 67 publications

References 20 publications

The analysis of antibiotic consumption and bacterial resistance in tertiary Healthcare Centre Nis

The analysis of antibiotic consumption and bacterial resistance in tertiary Healthcare Centre Nis

Adherence to European Association of Urology Guidelines on Prophylactic Antibiotics: An Important Step in Antimicrobial Stewardship

Fosfomycin Trometamol (3,000 mg) in Perioperative Antibiotic Prophylaxis of Healthcare-Associated Infections after Endourological Interventions: A Narrative Review

Contact Info

Product

Resources

About